NCT00001445View on ClinicalTrials.gov

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

August 31, 1995

Study Completion Date

July 31, 2001

Conditions

HIV Infection

Interventions

BIOLOGICAL

HIV-1 Immunogen

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH